Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Value of Admission Serum Il-8 Monitoring and the Detection of IL8 (-251 A/T) Polymorphism in Critically Ill Patients

NCT01708759 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT01708759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01708759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Value of Admission Serum Il-8 Monitoring and the Detection of IL8 (-251 A/T) Polymorphism in Critically Ill Patients
Lead sponsor
Tanta University
Phase
Observational
Overall status
Completed
Start date
November 30, 2012
Completion date
February 28, 2013
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, systemic inflammatory response syndrome